|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Abbott Laboratories, of Abbott Park, Ill., said the combination of Humira (adalimumab) with methotrexate in patients with active, long-standing rheumatoid arthritis resulted in significantly less structural joint damage and improved physical function and health-related quality of life at 52 weeks. Some Humira patients responded to treatment as soon as two weeks after their initial dose, according to the data published in the May issue of Arthritis and Rheumatism. Patients receiving Humira also reported significant improvements in clinical manifestations of the disease, such as swollen and tender joints and pain. Humira is approved in the U.S. for moderate to severe ...
Related newspaper, magazine, and journal articles:
|
|
Article: ADVANCED VIRAL INCREASES CREDIT LINE TO $50M TO ...
BIOWORLD Today;
February 20, 2001 ;
700+ words
...Advanced Viral Research Corp., almost five months ... purchase up to $50 million worth of Advanced Viral's common stock. The registration ... Gallantar, chief financial officer at Advanced Viral Research. "We tell them when we ...
|
|